Big Pharma green lights cannabis-based drug for epilepsy

“As a pharmaceutical product, it is the subject of rigorous and intense manufacturing controls. Patients have the reassurance that the product is what we say it is and what they think it is,” Justin Gover, GW’s chief executive officer, told the Post.

... read more at: https://www.salon.com/2018/02/10/big-pharma-green-lights-cannabis-based-drug-for-epilepsy_partner/

by